BMP4 and central nervous system cancer: To our knowledge, this is the first study to demonstrate that, in addition to serving as an anti‐glioma cargo, BMP4 can boost the innate migratory capacity of MSCs which could be utilized to enhance the migration for other applications requiring timely delivery (Figure S3a–c).